| SPEC | specificity |
|---|---|
| LNP | large neuronal polypeptide |
| NCL | neuronal ceroid-lipofuscinosis; nucleolin |
| SCN1A | sodium channel, neuronal alpha-subunit type 1 |
| CPSF | Cleavage and polyadenylation specificity factor |
|---|---|
| SP | Specificity |
| SPEC | specificity |
| DND | Delayed neuronal death |
| INCL | Infantile neuronal ceroid lipofuscinosis |
| analytical specificity | Freedom from interference by any element or compound other than the analyte. (05 Mar 2000) |
|---|---|
| antibody specificity | The property of antibodies which enables them to react with some antigenic determinants and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. (12 Dec 1998) |
| biological specificity | <biology, zoology> The specific, orderly patterns of development and metabolism which define and characterise an individual and its species. (21 Mar 1998) |
| relative specificity | The specificity of a medical screening test as determined by comparison with the same type of test (e.g., specificity of a new serological test relative to specificity of an established serological test). (05 Mar 2000) |
| sensitivity and specificity | Measures for assessing the results of diagnostic and screening tests. Sensitivity represents the proportion of truly diseased persons in a screened population who are identified as being diseased by the test. It is a measure of the probability of correctly diagnosing a condition. Specificity is the proportion of truly nondiseased persons who are so identified by the screening test. It is a measure of the probability of correctly identifying a nondiseased person. (12 Dec 1998) |
| species specificity | Restriction of a characteristic or response to the members of one species; it usually refers to that property of the immune response which differentiates one species from another on the basis of antigen recognition, but the concept is not limited to immunology and is used loosely at levels higher than the species. (12 Dec 1998) |
| specificity | The ability of the immune response to interact with individual antigens. (09 Oct 1997) |
| specificity constant | Ratio of the maximum velocity (Vmax) or kcat to the true Km value for a specific substrate in an enzyme-catalyzed reaction. (05 Mar 2000) |
| substrate specificity | A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. (12 Dec 1998) |
| diagnostic specificity | The probability (P) that, given the absence of disease (D), a normal test result (T) excludes disease; i.e., P(T/D). (05 Mar 2000) |
| organ specificity | Restriction of a characteristic or response to a particular organ of the body; it usually refers to that property of the immune response which differentiates one organ from another on the basis of antigen recognition, but the concept is not limited to immunology. (12 Dec 1998) |
| adrenergic neuronal blocking agent | A drug that prevents the release of norepinephrine from sympathetic nerve terminals; it does not inhibit the responses of the adrenergic receptors to circulating epinephrine, norepinephrine, and other adrenergic amines. (05 Mar 2000) |
| cell adhesion molecules, neuronal | Surface ligands that mediate cell-to-cell adhesion and function in the assembly and interconnection of the vertebrate nervous system. These molecules promote cell adhesion via a homophilic mechanism. These are not to be confused with ncam (neural cell adhesion molecule), now known to be expressed in a variety of tissues and cell types in addition to nervous tissue. (12 Dec 1998) |
| primary neuronal degeneration | <disease> A progressive, neurodegenerative disease characterised by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language. The cause of nerve cell death is unknown but the cells are recognised by the appearance of unusual helical protein filaments in the nerve cells (neurofibrillary tangles) and by degeneration in cortical regions of brain, especially frontal and temporal lobes. Alzheimer's disease is the most common cause of dementia. (22 May 1997) |
| neuronal | <anatomy> Pertaining to a neuron or neurons (= conducting cells of the nervous system). (18 Nov 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|